Lamiflam 3D Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Trypsin Chymotrypsin (50000 AU). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyretic action through central inhibition of prostaglandin synthesis, complementing the effects of Aceclofenac. Trypsin Chymotrypsin, a proteolytic enzyme complex, facilitates the reduction of inflammation and edema by promoting the breakdown of inflammatory mediators and fibrin deposits, enhancing tissue repair and recovery. This synergistic combination is indicated for the management of acute and chronic musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, soft tissue injuries, postoperative inflammation, and dental pain. Lamiflam 3D Tablet offers rapid relief from pain, inflammation, and swelling, improving patient mobility and quality of life. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or severe hepatic or renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, or allergic reactions. Patient adherence to prescribed dosage and duration is essential for optimal therapeutic outcomes.